Cat. No. | Name/Description | Purity |
---|---|---|
A615855 | Dimethylfraxetin | 98% |
A160451 | Methocarbamol | 98% |
A206081 | Topiramate | 98% |
A580496 | Polmacoxib | 97% |
A906540 | Benzolamide | 97% |
A128261 | Avadomide | 95% |
A112487 | U-104 | 98% |
A203568 | Sulfamide | 97% |
A126168 | Indisulam | 98% |
A120295 | Methazolamide | 98% |
A525496 | Dorzolamide HCl | 98% |
A1678235 | hCAI/II-IN-6 | 98% |
A1258800 | CAIX Inhibitor S4 | 98% |
A876758 | Ethoxzolamide | 98% |
A201176 | Dichlorphenamide | 98% |
A1868758 | hCAII-IN-8 | 98% |
A637802 | Sultiame | 99% |
A1417612 | EMAC10101d | 97% |
A184839 | 1,3-Dimethyluracil | 97% |
A436967 | Tioxolone | 98% |
Name/Description | Carbonic Anhydrase ↓ ↑ | Carbonic Anhydrase I ↓ ↑ | Carbonic Anhydrase II ↓ ↑ | Carbonic Anhydrase IV ↓ ↑ | Carbonic Anhydrase IX ↓ ↑ | Carbonic Anhydrase XII ↓ ↑ | Other Targets | Purity | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Topiramate | ✔ | Calcium Channel | 98% | ||||||||||||||||
Dichlorphenamide | ✔ | 98% | |||||||||||||||||
Mafenide Acetate | ✔ | 98% | |||||||||||||||||
Benzenesulphonamide | ✔ | 98% | |||||||||||||||||
Tioxolone |
+
CAI, Ki: 91 nM |
98% | |||||||||||||||||
Dorzolamide HCl |
+
Carbonic anhydrase I, Ki: 6000 nM |
++++
Carbonic anhydrase II, Ki: 1.9 nM |
+++
Carbonic anhydrase IV, Ki: 31 nM |
98% | |||||||||||||||
Methazolamide |
++
hCAI, Ki: 50 nM |
+++
hCAII, Ki: 14 nM |
++
bCAIV, Ki: 36 nM |
98% | |||||||||||||||
U-104 |
++
CAIX, Ki: 45.1 nM |
++++
CAXII, Ki: 4.5 nM |
98% | ||||||||||||||||
1. Hovering the mouse over the "+" can display the specific value of the relevant IC50. The more "+", the stronger the inhibitory effect. 2. "✔" Indicates that the compound has inhibitory effects on the corresponding subtypes, but there is currently no relevant data on the intensity of inhibition. |